|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/505 | |
| A61K 31/55 | |||
| A61K 38/17 |
| (11) | Patento numeris | 3058941 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16156290.5 |
| Europos patento paraiškos padavimo data | 2008-09-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 971144 P | 2007-09-10 | US | |
| 13372 | 2007-12-13 | US |
| (72) |
JIANG, Zhiwei, US
LI, Chiang, Jia, US
LI, Wei, US
LEGGETT, David, US
|
| (73) |
Boston Biomedical, Inc.,
640 Memorial Drive, Cambridge, MA 02139,
US
|
| (54) | NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS |
| NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS |